| DFMLX | PCBIX | DFMLX / PCBIX | |
| Total Expense Ratio | 0.79 | 0.67 | 118% |
| Annual Report Gross Expense Ratio | 0.95 | 0.67 | 142% |
| Fund Existence | 4 years | 25 years | - |
| Gain YTD | -3.405 | -2.920 | 117% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 309M | 29.5B | 1% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -7.31 | -10.93 | 67% |
| Returns for 3 years | 19.38 | 21.90 | 89% |
| Returns for 5 years | N/A | 14.21 | - |
| Returns for 10 years | N/A | 124.71 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| OPPJ | 52.10 | 1.41 | +2.78% |
| WisdomTree Japan Opportunities ETF | |||
| EDD | 5.91 | 0.07 | +1.20% |
| Morgan Stanley Emerging Markets Domestic Debt Fund | |||
| FGM | 67.93 | 0.73 | +1.08% |
| First Trust Germany AlphaDEX® ETF | |||
| UITB | 47.35 | 0.02 | +0.04% |
| VictoryShares Core Intermediate Bond ETF | |||
| IBRN | 32.98 | N/A | N/A |
| iShares Neuroscience and Healthcare ETF | |||